(PharmaNewsWire.Com, August 28, 2017 ) The Middle-East and Africa Liquid Biopsy market is expected to increase at a CAGR of 21.71% in the forecast period of 2016-2021 and reach a value of USD 157.50 million by 2021 from USD 59.02 million in 2016. Middle-East and Africa market is geographically segmented into Middle-East and Africa.
Liquid Biopsy Market Growth helps in collection of a wide range of information about a cancer/tumour through a simple blood sample. The procedure can help in exact detection of mutations in epidermal growth factor receptors in cancers. Liquid biopsies are also helpful in residual cancer detection which can be performed with 5 millilitres of blood that would detect present state of metastases in various tumours.
Rising number of cancer patients in the world coupled with innovation in liquid biopsy technology is anticipated to drive the global liquid biopsy market over the forecast period. However, expensive medical procedures & cost intensive research process involved in liquid biopsy is anticipated to restrain the development of the global liquid biopsy market over next few years.
The liquid biopsy market is mainly segmented by types of cancer into Lung Cancer, Pancreatic Cancer, Leukemia and Other Visceral Cancers. By Diagnostic approach they can be classified as Circulating Tumour cells (CTC), Circulating Tumour DNA (ctDNA), RNA in exosomes and Extra-Cellular Vesicles. Based on end users, the market is segmented into reference laboratories, hospital/physician laboratories, academic and research centers, and other end users. The market is bifurcate into blood, urine, plasma, saliva and Cerebrospinal fluid based upon sample type.
CTCs (Circulating Tumour cells), is gaining popularity and have accounted for a large share in the market. Cancer institute is the largest end user segment in terms of revenues and is expected to create substantial opportunity in global liquid biopsy market over the forecast period.
The key players dominating the liquid biopsy market are Janssen Diagnostics, Qiagen, Rarecells SAS, Silicon Biosystems, SRI International, Myriad Genetics, Natera, Personal Genome Diagnostics, Sysmex Inostics, Trovagene, Exosome Diagnostics, Exosome Sciences, and HansaBiomed OU.
About Us:
Market Data Forecast is a firm working in the area of market research and business intelligence. With rich experience in research across various business domains, we cater to the needs of both individual and corporate clients. Our analyst team comprises expert professionals in market research, who with their collective knowledge and skillset dedicatedly serve clients from various industries and regions.
We are pleased to offer you this exciting, new, and entirely free professional resource. Visit our Free Biotechnology & Pharmaceuticals resource center today to browse our selection of 600+ complimentary Biotechnology & Pharmaceuticals magazines, white papers, webinars, podcasts, and more. Get popular titles including:
